Literature DB >> 11424017

Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue.

D J Bidanset1, R J Rybak, C B Hartline, E R Kern.   

Abstract

Because human cytomegalovirus (HCMV) infection and replication are limited to human cells, few animal models can be used to specifically examine the biology of HCMV in vivo. In these studies, fetal human retinal tissue was implanted into the anterior chamber of the severe combined immunodeficient (SCID) mouse eye and subsequently was inoculated with HCMV. Viral replication, localized to glial cells in the xenografts, was first detected 7 days after infection. Thereafter, HCMV replication increased to peak levels through days 21-28 and then gradually decreased to undetectable levels by 8 weeks after infection. The clinical isolate Toledo replicated to higher titers than did strain AD169 or Towne. A comparison of implant age indicated that older tissue could support higher levels of HCMV replication than could younger implants. SCID mice implanted with human retinal tissue provide an excellent model for evaluation of HCMV infection of an ocular structure in vivo.

Entities:  

Mesh:

Year:  2001        PMID: 11424017     DOI: 10.1086/322015

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  Cytomegalovirus antivirals and development of improved animal models.

Authors:  Alistair McGregor; K Yeon Choi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-09-01       Impact factor: 4.481

Review 2.  Humanized mouse models of genetic immune disorders and hematological malignancies.

Authors:  Rajeev K Tyagi; Jing Li; Justin Jacobse; Scott B Snapper; Dror S Shouval; Jeremy A Goettel
Journal:  Biochem Pharmacol       Date:  2019-10-18       Impact factor: 5.858

3.  Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.

Authors:  M Shane Smith; Devorah C Goldman; Alexis S Bailey; Dana L Pfaffle; Craig N Kreklywich; Doran B Spencer; Florence A Othieno; Daniel N Streblow; J Victor Garcia; William H Fleming; Jay A Nelson
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

4.  Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice.

Authors:  Weijia Wang; Shannon L Taylor; Stacey A Leisenfelder; Robert Morton; Jennifer F Moffat; Sergey Smirnov; Hua Zhu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 5.  Humanized mouse models of human cytomegalovirus infection.

Authors:  Lindsey B Crawford; Daniel N Streblow; Morgan Hakki; Jay A Nelson; Patrizia Caposio
Journal:  Curr Opin Virol       Date:  2015-06-25       Impact factor: 7.090

6.  Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.

Authors:  Earl R Kern; Deborah J Bidanset; Caroll B Hartline; Zhaohua Yan; Jiri Zemlicka; Debra C Quenelle
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

8.  Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections.

Authors:  Earl R Kern; Caroll B Hartline; Rachel J Rybak; John C Drach; Leroy B Townsend; Karen K Biron; Deborah J Bidanset
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  A model of human cytomegalovirus infection in severe combined immunodeficient mice.

Authors:  Fernando J Bravo; Rhonda D Cardin; David I Bernstein
Journal:  Antiviral Res       Date:  2007-07-10       Impact factor: 5.970

Review 10.  Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion.

Authors:  Niels A W Lemmermann; Kai A Kropp; Christof K Seckert; Natascha K A Grzimek; Matthias J Reddehase
Journal:  J Biomed Biotechnol       Date:  2010-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.